Compugen (CGEN) Tax Provisions (2013 - 2026)
Compugen (CGEN) posted quarterly Tax Provisions of $5000.0 for Q1 2026, down 83.87% year-over-year from $31000.0 in Q1 2025, and down 95.37% on a QoQ basis from $108000.0 in Q4 2025.
Powered by 
Analysis
Compugen (CGEN) Tax Provisions (2013 - 2026) Analysis & Trends
Compugen has reported Tax Provisions for 9 years, with the latest figure at $5000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $5000.0, down 83.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $28000.0 (up 100.62% YoY), and the FY2025 annual result was $54000.0, down 98.81% from the prior year.
- Tax Provisions retreated to $5000.0 in Q1 2026, from $108000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $9.0 million in Q4 2023 and troughed at -$4.5 million in Q3 2024.
- A 5-year average of $357307.7 and a median of $5000.0 in 2026 frame the typical range for Tax Provisions.
- The widest annual swing landed in 2023, when Tax Provisions jumped 15427.59%; it then slumped 173.91% in 2024.
- A 5-year view of Tax Provisions shows it stood at $58000.0 in 2022, then jumped by 15427.59% to $9.0 million in 2023, then sank by 99.96% to $4000.0 in 2024, then surged by 2600.0% to $108000.0 in 2025, then tumbled by 95.37% to $5000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $5000.0 in Q1 2026, $108000.0 in Q4 2025, and -$40000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Compugen | 241.97 Mn | 156.35 Mn | -92,000.00 | -17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -4.50 Mn |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 8.93 Mn |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2021 | -2.02 Mn |
| Sep 30, 2021 | 2.02 Mn |
| Dec 31, 2016 | -40,000.00 |
| Dec 31, 2015 | 390,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Jun 30, 2014 | -60,000.00 |
| Dec 31, 2013 | 345,000.00 |